{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:21:52Z","timestamp":1761862912774},"reference-count":35,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2010,11,23]],"date-time":"2010-11-23T00:00:00Z","timestamp":1290470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:styled-content>Objective<\/jats:styled-content>: The study sought to examine the total weight of evidence regarding the use of drug eluting (DES) and bare metal stents (BMS) in patients with end stage renal disease (ESRD). <jats:styled-content>Background<\/jats:styled-content>: The potential superiority of DES over BMS in reducing target lesion or vessel revascularization (TLR or TVR) in patients with ESRD on dialysis has not been established. Small studies comparing DES to BMS in this population have yielded inconclusive results mainly due to the small sample size. <jats:styled-content>Methods<\/jats:styled-content>: We searched MEDLINE, EMBASE, Science Citation Index, CINAHL, and the Cochrane CENTRAL database of controlled clinical trials (December 2009) for controlled trials comparing DES to BMS in ESRD patients. We conducted a fixed\u2010effects meta\u2010analysis across seven eligible studies (<jats:italic>n<\/jats:italic> = 869 patients). <jats:styled-content>Results<\/jats:styled-content>: Compared with BMS\u2010treated patients, DES\u2010treated patients had significantly lower TLR\/TVR (OR 0.55 CI: 0.39\u20130.79) and major adverse cardiac events (MACE) (OR 0.54; CI: 0.40\u20130.73). The absolute risk reduction (ARR) with DES in TLR\/TVR was \u22120.09 (CI: \u22120.14 to \u22120.04; NNT 11) and in MACE was \u22120.13 (CI: \u22120.19 to \u22120.07; NNT 8). A trend towards lower incidence of all cause mortality was also noted with DES (OR 0.68; CI: 0.45\u20131.01). No significant differences were noted between both groups in the relative or absolute risk of myocardial infarction. <jats:styled-content>Conclusion<\/jats:styled-content>: The use of DES in patients with ESRD is safe and yields significant reduction in the risk of TLR\/TVR and MACE. Larger randomized studies are needed to confirm the results of this meta\u2010analysis and establish the appropriate stent choice in this high risk population. \u00a9 2010 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ccd.22562","type":"journal-article","created":{"date-parts":[[2010,3,26]],"date-time":"2010-03-26T17:16:13Z","timestamp":1269623773000},"page":"942-948","source":"Crossref","is-referenced-by-count":26,"title":["Drug\u2010eluting stents in patients with end\u2010stage renal disease: Meta\u2010analysis and systematic review of the literature"],"prefix":"10.1002","volume":"76","author":[{"given":"Ahmed","family":"Abdel\u2010Latif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debabrata","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paymon","family":"Mesgarzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled M.","family":"Ziada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,11,23]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004090765"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809173391203"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-989396"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.01.002"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.07.023"},{"key":"e_1_2_5_7_2","unstructured":"USRDS. USRDSA.Atlas of Chronic Kidney Disease and End\u2010Stage Renal Disease in the United States. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases Bethesda MD 2008."},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001934"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.11.1377"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.72.56"},{"key":"e_1_2_5_11_2","first-page":"405","article-title":"Impact of drug\u2010eluting stents on outcomes of patients with end\u2010stage renal disease undergoing percutaneous coronary revascularization","volume":"18","author":"Das P","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"e_1_2_5_12_2","first-page":"577","article-title":"Clinical outcomes following percutaneous coronary intervention with drug\u2010eluting vs. bare\u2010metal stents in dialysis patients","volume":"18","author":"Halkin A","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.71.1525"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.2009.00495.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-08-0010"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.01.263"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)04149-5"},{"key":"e_1_2_5_18_2","unstructured":"WellsG SheaB O'ConnellD PetersonJ WelchV LososM TugwellP. The Newcastle\u2010Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta\u2010analysis. The ottawa health research institute: ottawa Canada. Available at:http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/nosgen.doc2005."},{"key":"e_1_2_5_19_2","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel N","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470693926.ch15"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.01.006"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-4758.2008.00316.x"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804626"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl835"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.580084"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.24.2973"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012843"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035071"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032441"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.24.2868"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.781377"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010746"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.21016"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.08.089"},{"key":"e_1_2_5_36_2","first-page":"331","article-title":"Short\u2010 and long\u2010term clinical outcomes of coronary drug\u2010eluting stent recipients presenting with chronic renal disease","volume":"19","author":"Mishkel GJ","year":"2007","journal-title":"J Invasive Cardiol"}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fccd.22562","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.22562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T13:25:35Z","timestamp":1696857935000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.22562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,23]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1002\/ccd.22562"],"URL":"https:\/\/doi.org\/10.1002\/ccd.22562","archive":["Portico"],"relation":{},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"value":"1522-1946","type":"print"},{"value":"1522-726X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,23]]}}}